Quick search

Robert Jappie

Partner - Life Science & Cannabis Regulation London T +44 (0) 20 7481 0010

Department Regulatory solutions Qualified England and Wales 2008 Education (University) BPP Law School – LLM University of Wales, Swansea - LLB Languages English

Robert Jappie

You, Robert Jappie
& Ince, in any case

Robert Jappie is a partner in the London office at Ince, specialising in Life Sciences and Cannabis Regulation for the UK and Europe. Robert is able to provide advice and expertise in relation to the following matters:
  • CBD Regulation and Compliance
  • Cannabis Based Medicinal Products (CBPMs) – routes to market
  • EU Novel Food Regulations and Marketing Authorisation Submissions
  • Cultivation license applications
  • Cosmetic product regulations
  • Healthcare and Health-tech regulatory submissions
  • Covid-19 related regulatory approvals
  • Medical Device approval
  • Product Compliance and Formulation
  • Import/Export best practice
  • POCA concerns for the Cannabis investment sector
  • Psychedelics

New industries present new opportunities, and with these opportunities arise new risks. The risk is one of regulatory intervention. If managed correctly, such regulatory interventions can be turned into an opportunity for a business to improve its compliance and develop a longstanding, positive relationship with the relevant regulators. Robert’s expertise in making regulatory applications, obtaining regulatory approvals and defending interventions can mitigate these risks in order to allow innovation to flourish.

Robert has advised companies in relation to licensing and regulatory submissions to the MHRA, FSA, CQC and the Home Office. Due to his unique expertise he has become a leading legal expert in the European cannabis industry and has re-enforced the firm’s position as a global leader in Regulatory Solutions.

Professional associations & memberships 

Member of the International Bar Association (IBA)

URLs to online publications

Recent cases of note:

Provacan – regulatory and commercial support for one of the leading CBD brands.

CanXchange – a CBD and Medicinal Cannabis trading platform, on their regulatory compliance.

Haloverify - Halo is a rapid Covid-10 testing service which provides diagnostic screening to the UK private sector.

Pleasant Lands Campaign by Volteface – Legal Advisor to the campaign to open up hemp farming in the UK.

Nominated for Business Development Innovation awards for the cannabis law endeavour – Legal Week and Law Society Awards 2019.

What you may not know about Robert

Robert is a big film buff. His knowledge of Hollywood blockbusters and Horror movies verges on the encyclopaedic. If he’s not at the cinema, or in the office, then you can find him at White Hart Lane cheering on his beloved Tottenham Hotspur FC.

My matter highlights

  1. Presented to the European Commission Working Group on Novel Foods in Brussels on behalf of the UK Cannabis Trades Association – March 2019.

  2. Advised Ignite International Brands on their UK CBD launch, which included the UK’s first CBD billboard advertising campaign – July 2019.

  3. Advised a US based medicinal cannabis company in relation to their introduction of Cannabis Based Products for Medicinal use (CBPMs) into the UK under the Specials Licence regime. Advised the same company in relation to the commencement of a clinical trials programme for a finished product CBPM – February 2019.

  4. Instructed by a Colombian based Licensed Producer to advise on product compliance, importation and marketing strategy in relation to their ingestible and cosmetic CBD products – 2019.

  5. Instructed by a well-known CBD brand in relation to their regulatory engagement with the Medicines and Healthcare Regulatory Agency (MHRA) in relation to medicinal claims compliance.

My recent publications

News / A Time for Courage

20-03-2020 /

“This is not a time for ideology and orthodoxy, this is a time to be bold, a time for courage.” Rishi Sunak, Chancellor of The Exchequer – 17th March 2020

A Time for Courage

News / CBD and Novel Foods: ACI provides more information

05-03-2020 /

More information on how the FSA Novel Food application procedure is going to work has been provided by the ACI. In particular they have provided further clarity on the application timetable and the likely cost burden on SMEs.

CBD and Novel Foods: ACI provides more information

Insights / CBD and Novel Foods – The Devil is in the Detail

19-02-2020 /

The Novel Food announcement by the FSA landed last week and created major waves in the CBD world. By then we had all been waiting on this guidance from the regulator for a long time. It wasn’t the announcement that I would have wanted, but like Brexit, whether you were for it or against it, it has happened. At this point in time, any kind of clarity is welcome. Now we await the formal protocols of the application process but there is enough information around for us to start getting into the detail.

CBD and Novel Foods – The Devil is in the Detail

News / Ince strengthens Regulatory Solutions team with the hire of new Partner Robert Jappie

11-02-2020 /

11 February 2020, London: International legal and professional services firm Ince has today announced the appointment of Robert Jappie, as a new Partner in the Regulatory Solutions team.

Ince strengthens Regulatory Solutions team with the hire of new Partner Robert Jappie